Browse All Mali Market Research Reports
List of reports from Mali
Displaying 1 to 15 (of 15 records)
| Pages: « Last 1 |
|
Malignant Glioma - Pipeline Review, H1 2013
May 2013 | By - Global Markets Direct
Malignant Glioma Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Malignant Glioma Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Malignant Glioma, complete with latest updates, and special features on late-stage and discontinued projects. It also...
|
$2000 |
|
Nonhematologic Malignancy Pipeline Review, H1 2013
Mar 2013 | By - Global Markets Direct
Nonhematologic Malignancy Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Nonhematologic Malignancy Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Nonhematologic Malignancy, complete with latest updates, and special features on late-stage and...
|
$2000 |
|
The Insurance Industry in Mali, Key Trends and Opportunities to 2017
Mar 2013 | By - Timetric
Synopsis
The report provides in depth market analysis, information and insights into the insurance industry in Mali, including:
The Malian insurance industry’s growth prospects by insurance segments and categories
The competitive landscape in the Senegalese insurance industry
The current trends and drivers of the Malian insurance industry
The...
|
$1950 |
|
Malignant Pleural Mesothelioma - Pipeline Review, H1 2013
Feb 2013 | By - Global Markets Direct
Malignant Pleural Mesothelioma Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Malignant Pleural Mesothelioma Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Malignant Pleural Mesothelioma, complete with latest updates, and special features on...
|
$2000 |
|
Malignant Mesothelioma - Pipeline Review, H1 2013
Feb 2013 | By - Global Markets Direct
Malignant Mesothelioma – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, 'Malignant Mesothelioma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Malignant Mesothelioma, complete with latest updates, and special features on late-stage...
|
$2000 |
|
Malignant Neoplasms - Pipeline Review, H1 2013
Feb 2013 | By - Global Markets Direct
Malignant Neoplasms Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Malignant Neoplasms Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Malignant Neoplasms, complete with latest updates, and special features on late-stage and discontinued projects....
|
$2000 |
|
Malignant Pleural Effusion - Pipeline Review, H2 2012
Dec 2012 | By - Global Markets Direct
Malignant Pleural Effusion Pipeline Review, H2 2012
Global Markets Directs, 'Malignant Pleural Effusion Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Malignant Pleural Effusion, complete with latest updates, and special features on late-stage and discontinued projects. It...
|
$2000 |
|
Recurrent Malignant Glioma - Pipeline Review, H2 2012
Dec 2012 | By - Global Markets Direct
Recurrent Malignant Glioma Pipeline Review, H2 2012
Summary
Global Markets Directs, 'Recurrent Malignant GliomaPipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Recurrent Malignant Glioma, complete with latest updates, and special features on late-stage and...
|
$2000 |
|
Advanced Malignancy Pipeline Review, H2 2012
Nov 2012 | By - Global Markets Direct
Advanced Malignancy Pipeline Review, H2 2012
Summary
Global Markets Directs, 'Advanced Malignancy Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Advanced Malignancy, complete with latest updates, and special features on late-stage and discontinued projects....
|
$2500 |
|
Nonhematologic Malignancy - Pipeline Review, H2 2012
Sep 2012 | By - Global Markets Direct
Nonhematologic Malignancy Pipeline Review, H2 2012
Global Markets Directs, 'Nonhematologic Malignancy Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Nonhematologic Malignancy, complete with latest updates, and special features on late-stage and discontinued projects....
|
$2000 |
|
Omalizumab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011 | By - GenericsWeb
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players.
This Pipeline Selector report covers Omalizumab
Examples of information found in this...
|
$1200 |
|
Malignant Mesothelioma Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Aug 2011 | By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Malignant Mesothelioma Therapeutics Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global malignant mesothelioma therapeutics market. The report identifies the key trends shaping and driving the global malignant mesothelioma therapeutics market....
|
$2000 |
|
Nonhematologic Malignancy Global Clinical Trials Review, Q1, 2011
Jan 2011 | By - GlobalData
GlobalData's clinical trial report, “Nonhematologic Malignancy Global Clinical Trials Review, Q1, 2011 provides data on the Nonhematologic Malignancy clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Nonhematologic Malignancy. It includes an overview of the trial numbers and their recruitment status as per the site...
|
$1000 |
|
Malignant Pleural Effusion Global Clinical Trials Review, Q4, 2010
Dec 2010 | By - GlobalData
GlobalData's clinical trial report, “Malignant Pleural Effusion Global Clinical Trials Review, Q4, 2010"" provides data on the Malignant Pleural Effusion clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Malignant Pleural Effusion. It includes an overview of the trial numbers and their recruitment status as per the site of...
|
$1000 |
|
Malignant Mesothelioma Global Clinical Trials Review, Q4, 2010
Dec 2010 | By - GlobalData
GlobalData's clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, Q4, 2010"" provides data on the Malignant Mesothelioma clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Malignant Mesothelioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial...
|
$1000 |
Displaying 1 to 15 (of 15 records)
| Pages: « Last 1 |
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
